AbbVie
ABBV
#26
Rank
S$517.80 B
Marketcap
S$292.98
Share price
-1.15%
Change (1 day)
27.66%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2025 : -S$3.37 Billion

According to AbbVie's latest financial reports the company has -S$3.37 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$4.57 B-66.7%
2023-12-31$S$13.73 B-40.75%
2022-12-31$S$23.17 B11.05%
2021-12-31$S$20.86 B20.44%
2020-12-31$S$17.32 B-257.27%
2019-12-31$-S$11.02 Billion-4.52%
2018-12-31$-S$11.54 Billion-269.25%
2017-12-31$S$6.81 B1.6%
2016-12-31$S$6.70 B20.24%
2015-12-31$S$5.58 B142.44%
2014-12-31$S$2.30 B-59.56%
2013-12-31$S$5.69 B38.39%
2012-12-31$S$4.11 B-73.39%
2011-12-31$S$15.45 B-23.61%
2010-12-31$S$20.22 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
S$120.64 B-3,681.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.10 B-815.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$30.90 B-1,017.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.46 B-470.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$27.80 B-925.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$23.59 B-800.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$27.44 B-914.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
S$59.57 B-1,868.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$3.89 B-215.57%๐Ÿ‡บ๐Ÿ‡ธ USA